MedTrace Logo

Evaluation by a Vineland II Scale of Long-term Development of Children With Pyridoxine Dependent Epilepsy

NCT06054347 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-08-11

No results posted yet for this study

Summary

This study aims to evaluate with the VINELAND II scale the long-term neurocognitive development of children above age 3 years with pyridoxine dependent epilepsy related to antiquitine deficiency.

Conditions

  • Pyridoxine-Dependent Epilepsy

Interventions

OTHER

VINELAND II

Standardised questionnaire filled by the investigator during an interview with the parents or with the patient himself if capable of it. Duration 1 hour to 1 hour and a half.

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Patrick VAN BOGAERT, PhD - MD · University Hospital, Angers

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-29
Primary Completion
2025-05-21
Completion
2025-05-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06054347 on ClinicalTrials.gov